Observational study on outcomes of ECIRS for kidney stones in Asia
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) in Asia
Chinese University of Hong Kong · NCT05894668
This study is looking at how well a specific kidney stone surgery called ECIRS works for patients in Asia by collecting information before and after their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 3 sites (Hong Kong and 2 other locations) |
| Trial ID | NCT05894668 on ClinicalTrials.gov |
What this trial studies
This observational, international, multicenter cohort study aims to collect clinical data on patients with urinary stones undergoing Endoscopic Combined Intrarenal Surgery (ECIRS) across various centers in Asia. It will gather baseline demographic information, symptoms, risk factors, and laboratory variables, as well as treatment details and perioperative outcomes. Follow-up data will be collected for up to three months post-surgery to analyze patterns of presentation and treatment effectiveness. The study seeks to enhance understanding of ECIRS outcomes in the context of renal stone management.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with urinary stones who are scheduled to undergo ECIRS and consent to participate.
Not a fit: Patients undergoing ECIRS for conditions other than urinary stones or those with incomplete intraoperative records may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with urinary stones undergoing ECIRS.
How similar studies have performed: Other studies have shown success with similar observational approaches in understanding surgical outcomes, making this study a valuable addition to existing knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with urinary calculi * Undergoing Endoscopic Combined Intrarenal Surgery (ECIRS) * Agreed to consent for the study Exclusion Criteria: * Patients who have ECIRS for other conditions, such as urothelial cancer etc. * Patients who intraoperative record was incomplete. * Patients only have either PCNL or ureteroscopy done (not both)
Where this trial is running
Hong Kong and 2 other locations
- Alice Ho Miu Ling Nethersole Hospital — Hong Kong, Hong Kong (RECRUITING)
- Prince of Wales Hospital — Shatin, Hong Kong (RECRUITING)
- North District Hospital — Sheung Shui, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Chi Fai NG, MD — Chinese University of Hong Kong
- Study coordinator: Chi Fai NG, MD
- Email: ngcf@surgery.cuhk.edu.hk
- Phone: 35052625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Renal Stone